Skip to content
10-K

Annual Report

GREENWICH LIFESCIENCES, INC. GLSI

0001493152-24-014625

← back to feed
Filed
Apr 15, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Apr 10, 2024 12.88M sh
Shares Diluted FY 2023 · Dec 31, 2022 12.91M sh
Stock Repurchased FY 2023 · Dec 31, 2022 $7.54M
Operating Cash Flow FY 2023 · Dec 31, 2022 −$6.2M
Cash And Equivalents FY 2023 · Dec 31, 2022 $13.47M
Current Liabilities FY 2023 · Dec 31, 2022 $262.91K
Total Liabilities FY 2023 · Dec 31, 2022 $262.91K
Total Assets FY 2023 · Dec 31, 2022 $13.48M
Eps Diluted FY 2023 · Dec 31, 2022 −$0.61
Eps Basic FY 2023 · Dec 31, 2022 −$0.61
Sga Expense FY 2023 · Dec 31, 2022 $1.56M
Rd Expense FY 2023 · Dec 31, 2022 $6.48M
Net Income FY 2023 · Dec 31, 2022 −$7.83M
Operating Income FY 2023 · Dec 31, 2022 −$8.04M
Stockholders Equity FY 2023 · Dec 31, 2021 $26.83M